Vsee Health Inc (VSEE) Stock Analysis
Verdict: AVOID
A liquidity crunch and accelerating net losses have triggered a death spiral, rendering technical 'value' secondary to insolvency risk.
Investment score: 18/100
Analysis as of
Is Vsee Health Inc stock worth reviewing? AI model thesis
VSee Health is facing an existential liquidity crisis. High revenue growth is being outpaced by operating expenses, leading to a share price melt-down from $2.52 to $0.079. Significant dilution risk makes fundamental valuation irrelevant at this stage.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 15/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
Vsee Health Inc opportunities and risks
What speaks for VSEE
- Revenue Growth Trajectory
What speaks against VSEE
- Insolvency and Liquidity Crunch
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| VSEE | n/a | 0.1x | n/a | 46.3% | -92.4% | -428.2% |
| IHAI | n/a | 0.0x | n/a | 0.0% | 0.0% | -12.1% |
| HLYK | n/a | 4.7x | n/a | 97.5% | -224.6% | -29.2% |
| DTRK | 2.8x | 0.0x | 0.1x | 81.2% | 37.3% | 43.5% |
| ACON | n/a | 16.6x | 2.3x | -58.9% | -10336.1% | -569.1% |
| Peer median | n/a | 2.4x | n/a | 40.6% | -112.3% | -20.7% |
Frequently asked questions about Vsee Health Inc (VSEE)
Is VSEE stock a good investment?
The cached TradeMates AI model rates Vsee Health Inc as AVOID with an investment score of 18/100. VSee Health is facing an existential liquidity crisis. High revenue growth is being outpaced by operating expenses, leading to a share price melt-down from $2.52 to $0.079. Significant dilution risk makes fundamental valuation irrelevant at this stage. This is algorithmic model output, not personal investment advice.
Is VSEE stock a buy?
The TradeMates model verdict for VSEE is AVOID with an investment score of 18/100. Treat this as a model signal to review, not a personal buy recommendation.